Anti-TIF-1 Antibody Positivity Is Associated with a Five-Fold Increase in Cancer Risk in the Idiopathic Inflammatory Myopathies

Alexander Oldroyd(Manchester Academic Health Science Centre), Hector Chinoy(Salford Royal NHS Foundation Trust), Jamie C. Sergeant(Manchester Academic Health Science Centre), Neil McHugh(University of Bath), Janine A. Lamb(University of Manchester), Paul New(University of Liverpool), William Ollier(University of Manchester), Zoë Betteridge(University of Bath), Robert G. Cooper(McMaster University)
Research Explorer (The University of Manchester)
September 18, 2017
Cited by 0

Related Papers

Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence
|Nature Genetics|2017|518
Erratum: Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence
|Nature Genetics|2017|376
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease
|Lara D. Veeken|2003|367
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort
|Breast Cancer Research|2015|258